List view / Grid view
29 April 2015 | By Victoria White
A recent survey has found that 52% of 275 ACS patients who were currently taking an oral antiplatelet have missed taking or changed the way they take it...
28 April 2015 | By Victoria White
TxCell has appointed Stéphane Boissel as CEO. In addition, Dr. Miguel Forte, previously SVP Clinical and Regulatory, has been promoted to COO...
28 April 2015 | By Victoria White
Open-label trial shows electroCore’s nVNS therapy does not cause any meaningful cardiovascular adverse effects in patients with asthma...
28 April 2015 | By Victoria White
Mylan has announced that its Board of Directors has unanimously rejected the unsolicited expression of interest from Teva to acquire the Company...
27 April 2015 | By Victoria White
Three posters on the Extended Spectrum Pleuromutilins (ESP) Programme and one poster on lefamulin were presented at ECCMID 2015...
Thermo Fisher Scientific Inc., the world leader in serving science, is unveiling new bioprocessing technologies to address the evolving needs for enhancing the efficiency and productivity of global biopharmaceutical manufacturers. These advancements include single-use systems, purification, cell culture media, analytical systems, adherent cell culture, customized fluid transfer systems and laboratory…
27 April 2015 | By
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) has issued a special excellence award to Médecins Sans Frontières...
27 April 2015 | By Victoria White
Professional medical writing improves the quality of clinical trial reporting, demonstrates a study presented at the 11th Annual Meeting of the ISMPP...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
27 April 2015 | By Victoria White
CHMP has adopted a positive opinion, approving BMS’ ClickJect Pre-Filled Pen for use in adult patients with moderate to severe active rheumatoid arthritis...
27 April 2015 | By Victoria White
AbbVie announced new, preliminary safety and efficacy data from the first cohort of its ongoing, Phase 3b RUBY-I study at ILC 2015...
27 April 2015 | By Victoria White
The FDA has approved Cyramza in combination with FOLFIRI chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC)...
27 April 2015 | By Victoria White
Primary endpoints were successfully met in a Phase III clinical trial evaluating a 12-week daclatasvir-based regimen for the treatment of patients with HCV...
24 April 2015 | By Victoria White
ELPA has launched ‘C: My Journey’, an online resource where people diagnosed with HCV can go to find out more about the condition and how to get support...
24 April 2015 | By Victoria White
Phase III trial results of the RTS,S vaccine candidate show that it helped protect children from clinical malaria for at least 3 years after vaccination...
